EPO Patents = 2

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Patrice Debre (3 out of 8 patents)

Vincent Vieillard (3 out of 3 patents)

Joël Crouzet (1 out of 9 patents)

4. Raphaël Ho Tsong Fang (1 out of 1 patent)

5. Dominique Desfontaines (1 out of 1 patent)

6. Laurence Meyer (2 patents)

4 patents: Sort by Forward Citations

1. 10174080 - Compositions for preventing and/or treating an infection by an HIV-1 virus (2019-01-08),

2. 9802983 - Compositions for preventing and/or treating an infection by an HIV-1 virus (2017-10-31),

3. 9511136 - Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein (2016-12-06),

4. 9181299 - Compositions for detecting an infection by an HIV-1 virus (2015-11-10),

Innavirvax is a biotechnology company focused on developing novel vaccines and therapeutics for infectious diseases. Our team of scientists and researchers are dedicated to advancing the field of immunology through innovative research and development. Our goal is to create safe and effective solutions to combat emerging and re-emerging infectious diseases, ultimately improving global health and well-being.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

4 Patents

#13 in Evry

#3,275 in France

Evry, France

Innavirvax